|
Volumn 32, Issue 3, 2000, Pages 626-628
|
Results of treatment in renal transplant patients with Kaposi sarcoma: One-center experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BLEOMYCIN;
CYCLOSPORIN A;
DOXORUBICIN;
ETOPOSIDE;
PREDNISOLONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
FEMALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KAPOSI SARCOMA;
KIDNEY TRANSPLANTATION;
MALE;
NAUSEA;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SCHOOL CHILD;
TREATMENT OUTCOME;
TUMOR VOLUME;
VOMITING;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
COMBINED MODALITY THERAPY;
DRUG THERAPY, COMBINATION;
ETOPOSIDE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
SARCOMA, KAPOSI;
TREATMENT OUTCOME;
|
EID: 0034100855
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)00922-2 Document Type: Conference Paper |
Times cited : (9)
|
References (11)
|